Učitavanje...
Comparative Review of Oral P2Y(12) Inhibitors
Current practice guidelines recommend dual antiplatelet therapy comprised of aspirin and a purinergic signaling receptor Y(12) (P2Y(12)) for patients following acute coronary syndrome. This article compares the efficacy, safety, and other characteristics of the three available oral P2Y(12) inhibitor...
Spremljeno u:
| Izdano u: | P T |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MediMedia USA, Inc.
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5969212/ https://ncbi.nlm.nih.gov/pubmed/29896034 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|